For increased power to demonstrate a relationship between HAS1 SNPs and the risk of a B-cell malignancy, three case cohorts (MM, CLL and WM) were pooled for analysis (Figure 2). This evidence concerns the gene HAS1 and B-cell chronic lymphocytic leukemia.